CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies

Central nervous system (CNS) relapse of diffuse large B-cell lymphoma (DLBCL) is a devastating event occurring in ~ 5% of patients treated with R-CHOP. We hypothesized that adding lenalidomide to R-CHOP (R2CHOP) may decrease the risk of CNS relapse. We analyzed records for patients with DLBCL from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayed, Ayed O., Chiappella, Annalisa, Pederson, Levi, Laplant, Betsy R., Congiu, Angela Giovanna, Gaidano, Gianluca, Spina, Michele, Re, Alessandro, Cavallo, Federica, Musuraca, Gerardo, Macon, William R., Witzig, Thomas, Vitolo, Umberto, Nowakowski, Grzegorz S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018787/
https://www.ncbi.nlm.nih.gov/pubmed/29946110
http://dx.doi.org/10.1038/s41408-018-0097-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018787/
https://www.ncbi.nlm.nih.gov/pubmed/29946110
http://dx.doi.org/10.1038/s41408-018-0097-0

Ejemplares similares